Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically?

Johnson MW.

Am J Ophthalmol. 2013 Feb;155(2):203-205.e1. doi: 10.1016/j.ajo.2012.10.016. No abstract available.

PMID:
23312439
2.

Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction.

Rodrigues IA, Stangos AN, McHugh DA, Jackson TL.

Am J Ophthalmol. 2013 Feb;155(2):270-276.e2. doi: 10.1016/j.ajo.2012.08.018. Epub 2012 Nov 17.

PMID:
23164159
3.

Novel possibility of vitreomacular traction treatment.

Michalska-Małecka K, Witek K, Sierocka-Stępień J, Wyględowska-Promieńska D, Nowak M.

Acta Ophthalmol. 2016 Dec;94(8):e818-e819. doi: 10.1111/aos.13075. Epub 2016 May 11. No abstract available.

PMID:
27167161
4.

Knowledge of vitreomacular traction (VMT) scenarios: Is doing nothing still a beneficial alternative and, if so, when?

Ziemssen F, Bartz-Schmidt KU, Dimopoulos S.

Graefes Arch Clin Exp Ophthalmol. 2016 Apr;254(4):615-6. doi: 10.1007/s00417-016-3301-6. Epub 2016 Feb 18. No abstract available.

PMID:
26887826
5.

Microplasmin for vitreomacular traction.

Udaondo P, Diaz-Llopis M, Garcia-Delpech S, Salom D, Arevalo JF.

Ophthalmology. 2010 Sep;117(9):1859, 1859.e1; author reply 1859-60. doi: 10.1016/j.ophtha.2010.06.004. No abstract available.

PMID:
20816250
6.

Incomplete release of vitreomacular attachments after intravitreal ocriplasmin.

Jeng KW, Baumal CR, Witkin AJ, Witkin SR, Wiegand TW, Waheed NK.

Ophthalmic Surg Lasers Imaging Retina. 2015 Feb;46(2):271-4. doi: 10.3928/23258160-20150213-02.

PMID:
25707057
7.

Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis.

Stalmans P, Duker JS, Kaiser PK, Heier JS, Dugel PU, Gandorfer A, Sebag J, Haller JA.

Retina. 2013 Nov-Dec;33(10):2003-11. doi: 10.1097/IAE.0b013e3182993ef8. Review.

PMID:
23881226
8.

Correspondence.

Primavera V, Querques G.

Retina. 2014 Dec;34(12):e39-40. doi: 10.1097/IAE.0000000000000384. No abstract available.

PMID:
25407235
9.

Reply: To PMID 23881226.

Stalmans P, Duker JS.

Retina. 2015 Apr;35(4):e28-9. doi: 10.1097/IAE.0000000000000597. No abstract available.

PMID:
25807179
10.

Vitreomacular traction syndrome.

Martins TG, Martins TG, Rodriguez EE, Costa AL.

Einstein (Sao Paulo). 2015 Apr-Jun;13(2):334-5. doi: 10.1590/S1679-45082015AI2979. Epub 2015 May 1. English, Portuguese. No abstract available.

11.

Anatomic and visual outcomes of vitrectomy for vitreomacular traction syndrome.

Witkin AJ, Patron ME, Castro LC, Reichel E, Rogers AH, Baumal CR, Duker JS.

Ophthalmic Surg Lasers Imaging. 2010 Jul-Aug;41(4):425-31. doi: 10.3928/15428877-20100525-07. Epub 2010 May 28.

PMID:
20608611
12.

Pathology of Internal Limiting Membrane Specimens Following Intravitreal Injection of Ocriplasmin.

Schumann RG, Wolf A, Mayer WJ, Compera D, Hagenau F, Ziada J, Kampik A, Haritoglou C.

Am J Ophthalmol. 2015 Oct;160(4):767-78. doi: 10.1016/j.ajo.2015.06.020. Epub 2015 Jun 29.

PMID:
26133247
13.

Improved efficacy of ocriplasmin for vitreomacular traction release and transient changes in optic disk morphology.

Willekens K, Abegão Pinto L, Vandewalle E, Stalmans I, Stalmans P.

Retina. 2015 Jun;35(6):1135-43. doi: 10.1097/IAE.0000000000000507.

PMID:
25719990
14.

EFFICACY AND SAFETY OF TREATMENT OPTIONS FOR VITREOMACULAR TRACTION: A Case Series and Meta-Analysis.

Yu G, Duguay J, Marra KV, Gautam S, Le Guern G, Begum S, Sharifzadeh A, Arroyo JG.

Retina. 2016 Jul;36(7):1260-70. doi: 10.1097/IAE.0000000000000909.

PMID:
26783988
15.

Early evolution of the vitreomacular interface and clinical efficacy after ocriplasmin injection for symptomatic vitreomacular adhesion.

Meyer JC, Shah GK, Blinder KJ, Waheed NK, Reichel E, Stalmans P, Singer M, Tewari A.

Ophthalmic Surg Lasers Imaging Retina. 2015 Feb;46(2):209-16. doi: 10.3928/23258160-20150213-21.

PMID:
25707046
16.

Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.

Hong J, Deng SX, Xu J.

N Engl J Med. 2012 Nov 22;367(21):2053; author reply 2054. doi: 10.1056/NEJMc1211068#SA3. No abstract available.

PMID:
23171110
17.

Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.

Rao RC, Dlouhy BJ.

N Engl J Med. 2012 Nov 22;367(21):2053; author reply 2054. doi: 10.1056/NEJMc1211068#SA2. No abstract available.

PMID:
23171109
18.

Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.

Huang J, Wen D, Wang Q.

N Engl J Med. 2012 Nov 22;367(21):2052-3; author reply 2054. doi: 10.1056/NEJMc1211068#SA1. No abstract available.

PMID:
23171108
19.

Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials.

Haller JA, Stalmans P, Benz MS, Gandorfer A, Pakola SJ, Girach A, Kampik A, Jaffe GJ, Toth CA; MIVI-TRUST Study Group.

Ophthalmology. 2015 Jan;122(1):117-22. doi: 10.1016/j.ophtha.2014.07.045. Epub 2014 Sep 18.

PMID:
25240630
20.

Optical coherence tomography imaging of surgical resolution of bilateral vitreomacular traction syndrome related to incomplete posterior vitreoschisis: a case report.

Carpineto P, Ciancaglini M, Aharrh-Gnama A, Cirone D, Mastropasqua L.

Eur J Ophthalmol. 2004 Sep-Oct;14(5):438-41.

PMID:
15506608

Supplemental Content

Support Center